Memphasys Ltd (IG7) AI Stock Analysis

Memphasys Ltd

(Frankfurt:IG7)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue GrowthThe strong revenue growth indicates increasing demand for Memphasys's fertility technologies, suggesting successful market penetration and potential for future sales expansion.

Negative Factors

Profitability ChallengesOngoing profitability issues may hinder Memphasys's ability to reinvest in growth and innovation, potentially impacting its long-term financial health and competitive position.

Memphasys Ltd (IG7) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap: EUR 12.38M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.5
Beta (1Y): 0.05
Revenue Growth: 7176.16%
EPS Growth: 41.18%
Country: Germany
Employees: 24
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Memphasys Ltd Business Overview & Revenue Model

Company Description

Memphasys Limited, an Australian enterprise, is dedicated to the development, manufacturing, and distribution of advanced cell and protein separation technologies, alongside associated consumable goods, for the healthcare, veterinary, and biotechnolo...

Memphasys Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:IG7 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AU:CTE	61Neutral	AUD 59.55M	26.64	52.84%	―	18.31%	18.65%
AU:MVF	54Neutral	AUD 280.54M	37.70	2.95%	3.47%	-0.90%	-70.25%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:AT1	45Neutral	AUD 12.63M	-3.33	-48.97%	―	40.65%	45.45%
AU:PGC	43Neutral	AUD 256.57M	-16.14	-5.34%	―	1.84%	-178.23%
AU:GSS	39Underperform	AUD 17.72M	-1.27	-35.10%	―	-9.10%	31.75%

* Healthcare Sector Average

Performance Comparison

DE:IG7 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:IG7	Memphasys Ltd	―	―	―
AU:PGC	Paragon Care Limited	0.15	-0.17	-51.56%
AU:AT1	Atomo Diagnostics Ltd.	0.01	-0.02	-53.33%
AU:CTE	Cryosite Limited	1.22	0.03	2.52%
AU:GSS	Genetic Signatures Ltd.	0.08	-0.24	-75.63%
AU:MVF	Monash IVF Group Ltd	0.74	0.08	11.86%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Memphasys Ltd AI Stock Analysis